AI assistant
Sending…
Celldex Therapeutics, Inc. — Director's Dealing 2010
Sep 14, 2010
31801_dirs_2010-09-14_ffd85f50-9799-45bc-a762-8002b0755854.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2010-09-13
Reporting Person: PAREKH RAJESH R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-13 | Common Stock | P | 40000 | $3.7337 | Acquired | 40000 | Direct |
More from Celldex Therapeutics, Inc.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
May 6
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 2
Capital/Financing Update
2026
Apr 2
Capital/Financing Update
2026
Apr 1
Major Shareholding Notification
2026
Mar 26